| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0006 |